Skip to main content
. 2016 Jul;4(14):261. doi: 10.21037/atm.2016.04.01

Figure 1.

Figure 1

Cancer immunotherapy approaches are classified into passive and active. Passive immunotherapy includes the use of tumor-specific mAbs, cytokines and adoptive cell transfer, whereas active immunotherapy refers to peptide, DC or allogeneic whole cell vaccines, checkpoint inhibitors and oncolytic viruses. DC, dendritic cell.